D. E. Shaw & Co., Inc. Omeros Corp Transaction History
D. E. Shaw & Co., Inc.
- $114 Billion
- Q1 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Omeros Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,677,683 shares of OMER stock, worth $6.81 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,677,683
Previous 1,492,303
12.42%
Holding current value
$6.81 Million
Previous $4.88 Million
18.63%
% of portfolio
0.01%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding OMER
# of Institutions
107Shares Held
26MCall Options Held
299KPut Options Held
520K-
Ingalls & Snyder LLC New York, NY4.7MShares$19.1 Million0.72% of portfolio
-
Black Rock Inc. New York, NY4.21MShares$17.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.25MShares$13.2 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.91MShares$7.75 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.38MShares$5.59 Million0.0% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $255M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...